The California Supreme Court issued a decision today in the Cipro antitrust cases, concluding that the analysis set forth by the U.S. Supreme Court in FTC v. Actavis applies to alleged “pay-for-delay” pharmaceutical patent...more
For the first time within the Third Circuit, a court has added to the handful of decisions holding that the attorney-client privilege does not shield an antitrust compliance policy from disclosure in antitrust litigation. In...more